Technical Analysis for SOLTF - Sosei Group Corporation

Grade Last Price % Change Price Change
D 16.55 1.60% 0.2600
SOLTF closed up 1.6 percent on Thursday, March 4, 2021, on 37 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical SOLTF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Weak + Overbought Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Crossed Above 50 DMA Bullish 1.60%
Expansion Pivot Buy Setup Bullish Swing Setup 1.60%
Older End-of-Day Signals for SOLTF ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sosei Group Corporation Description

Sosei Group Corporation, a biopharmaceutical company, discovers, develops, and commercializes biopharmaceutical products worldwide. Its marketed products include Seebri/NVA237, an inhaled long-acting muscarinic antagonist indicated as a maintenance bronchodilator treatment for chronic obstructive pulmonary disease (COPD); Ultibro/QVA149, an inhalation capsule for the bronchodilator treatment of COPD; and NorLevo, an oral emergency contraceptive. The company's product pipeline consists of SO-1105, an antifungal agent, which is in Phase III clinical trial for the treatment of oropharyngeal candidiasis in immunocompromised patients; and APP13002 and APP13007, which are in pre-clinical stage for infectious eye diseases, such as cornea and conjunctivitis, and inflammation. It also develops JIT-2001 for cardiovascular disease and JIT-1007 for orphan diseases that are in pre-clinical stage; and discovers and develops pharmaceutical products targeting G protein-coupled receptors. In addition, the company is developing biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic diseases, and other indications. The company has a strategic collaboration with PeptiDream Inc. Sosei Group Corporation was founded in 1990 and is headquartered in Tokyo, Japan.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Cancer Biopharmaceutical Pharmaceutical Pharmaceutical Products Inflammation Cardiovascular Disease Addiction Metabolic Diseases Metabolic Disease A2 Pulmonary Disease Chronic Obstructive Pulmonary Disease Alzheimer's Disease Biopharmaceuticals Respiratory Therapy Migraine Biopharmaceutical Product Eye Disease Biopharmaceutical Products Chronic Lower Respiratory Diseases Conjunctivitis Orphan Disease Orphan Diseases Schizophrenia Copd Didi Eye Diseases Candidiasis Pulmonology Bronchodilator Combination Drugs Treatment Of Alzheimer's Disease Muscarinic Antagonists Pulmonary Function Testing

Is SOLTF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 237.05
52 Week Low 8.03
Average Volume 605
200-Day Moving Average 0.0000
50-Day Moving Average 16.1504
20-Day Moving Average 14.2435
10-Day Moving Average 13.9550
Average True Range 1.0745
ADX 13.69
+DI 54.2726
-DI 44.6325
Chandelier Exit (Long, 3 ATRs ) 15.5065
Chandelier Exit (Short, 3 ATRs ) 14.3835
Upper Bollinger Band 17.9335
Lower Bollinger Band 10.5535
Percent B (%b) 0.81
BandWidth 51.8131
MACD Line -0.5588
MACD Signal Line -1.0783
MACD Histogram 0.5195
Fundamentals Value
Market Cap 1.33 Billion
Num Shares 80.6 Million
EPS
Price-to-Sales 19.94
Price-to-Book 2.75
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.5500
Resistance 3 (R3) 16.5500 16.5500 16.5500
Resistance 2 (R2) 16.5500 16.5500 16.5500 16.5500
Resistance 1 (R1) 16.5500 16.5500 16.5500 16.5500 16.5500
Pivot Point 16.5500 16.5500 16.5500 16.5500 16.5500
Support 1 (S1) 16.5500 16.5500 16.5500 16.5500 16.5500
Support 2 (S2) 16.5500 16.5500 16.5500 16.5500
Support 3 (S3) 16.5500 16.5500 16.5500
Support 4 (S4) 16.5500